Dentures
Also known as: False teeth, Teeth, Tooth, Dental
Methodology & AI Transparency ⓘ
Dentures Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Dentures are false teeth made to replace teeth you have lost.
- 2 Real-world patient consensus: Clinical coding for Dentures uses ICD-10 Z97.2 across ENT & Hearing specialty care.
- 3 Typical cash cost range: Primary evaluation for Dentures incorporates flexible nasolaryngoscopy when in Dentures (Z97.2: voice/swallowing persists) and symptom diary review.
- 4 Top reported side effects / signs: Key ENT & Hearing biomarkers for Dentures (Z97.2): Periodontal Pocket Depth in Dentures (Z97.2: & Bleeding Index) & Pure-Tone Audiometry & in Dentures (Z97.2: Tympanometry) (Thresholds <= 20 dB HL; normal middle-ear pressure (Z97.2)).
Ask our AI Specialists anything about Dentures
What Is Dentures?
Dentures are false teeth made to replace teeth you have lost. They can be complete or partial. Complete dentures cover your entire upper or lower jaw. Partials replace one or a few teeth. Dentures may feel strange at first. Speaking and eating may feel different. Be careful when wearing dentures because they may make it harder for you to feel hot foods and liquids. Also, you may not notice biting on a bone from your food. In the beginning, your dentist may want to see you often to make sure the dentures fit. Over time, your mouth will change and you may need to have your dentures adjusted or replaced. Be sure to let your dentist handle these adjustments.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Dentures (Z97.2, ENT & Hearing) reflects or subgingival bacterial in Dentures (Z97.2: biofilm triggering periodontal). Cross-referenced with NIH MeSH (Dentures), longitudinal control is benchmarked via Periodontal Pocket Depth in Dentures (Z97.2: & Bleeding Index).
Common Symptoms & Clinical Signs
- • Presentation of Dentures (Z97.2): bleeding or receding in Dentures (Z97.2: gums, tooth sensitivity,)
- • Secondary Dentures clinical sign: muffled hearing, ear in Dentures (Z97.2: fullness, popping pressure,)
- • Symptom flares in Dentures correlating with Periodontal Pocket Depth in Dentures (Z97.2: & Bleeding Index) deviation outside Probing <= 3 mm without bleeding (Z97.2)
- • Functional ent & hearing impact requiring flexible nasolaryngoscopy when in Dentures (Z97.2: voice/swallowing persists) evaluation (Z97.2)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Dentures Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | Z97.2 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Ear, Nose, Throat & Oral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Periodontal Pocket Depth in Dentures (Z97.2: & Bleeding Index) | Probing <= 3 mm without bleeding (Z97.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pure-Tone Audiometry & in Dentures (Z97.2: Tympanometry) | Thresholds <= 20 dB HL; normal middle-ear pressure (Z97.2) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Dentures
Treatment selection for Dentures depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Dentures)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Eight-year long-term follow-up on the effectiveness of the quadrivalent human: What a 368-Participant Study Found There were another two HPV-related cases (non-vaccine HPV types) found in the placebo group. Human vaccines & immunotherapeutics • 2022-11-30 • Phase III Randomized Trial | N = 368 | 93/100 | PMID 35358015 ↗ |
| Can This Approach Help? Inside the Latest Research on Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide The addition of decitabine to BuCy conditioning reduced the risk of relapse with an acceptable safety profile in adult patients with KMT2A‑rearranged leukaemia and could be a suitable therapeutic option for this population. The Lancet. Haematology • 2026-11-15 • Phase III Randomized Trial | N = 65 | 82/100 | PMID 42956759 ↗ |
| Can This Approach Help? Inside the Latest Research on Defining clinically meaningful thresholds for forced vital capacity in patients Post hoc application of these thresholds to COMET showed that a greater proportion of patients in the AVA group had clinically meaningful improvement in FVC versus ALG. Journal of neuromuscular diseases • 2025-07-15 • Phase III Randomized Trial | N = 99 | 82/100 | PMID 40397025 ↗ |
| Can This Approach Help? Inside the Latest Research on Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 2.1%, p = 0.0421), rather than an increase in incidence (HR = 1.09, p = 0.2669). Nature communications • 2026-01-14 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 41535287 ↗ |
Dentures Patient Community & “People Like Me” Threads
Filter Dentures community threads and patient logs by age, biological sex, dosage, and treatment duration.